Artificial Cornea And Corneal Implant Market Report 2023-2028

1. Artificial Cornea And Corneal Implant Market Report 2023 By Type, Transplant Type, disease Indication and End User Key Regions and Competitive Landscape www.imarcgroup.com Sales@imarcgroup.com +1-631-791-1145 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value challenges, and transform their businesses. opportunities, address their most critical IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. technology IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description GlobalArtificial Cornea And Corneal Implant Market Outlook 2023-2028: The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028. The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028. Artificial cornea and corneal implant refer to the medical procedures that are conducted to replace the damaged cornea with healthy corneal tissue. They are usually performed for the treatment of numerous diseases, such as infectious keratitis, corneal ulcers, keratoconus, Fuchs dystrophy, etc. These procedures include various surgical techniques, including endothelial keratoplasty and penetrating, that involve the transplantation of the entire corneal stem cells. Artificial cornea and corneal implants are available in biosynthetic and synthetic variants that are manufactured using chemical substances and recombinant collagen. These procedures aid in relieving pain, restoring vision, treating damaged corneas, etc. As a result, they find widespread applications in several hospitals, ambulatory surgical centers (ASCs), specialty clinics, etc.

4. Report Description and Highlights Report Description Global Artificial Cornea And Corneal Implant Market Trends: The rising prevalence of eye-related disorders is primarily driving the artificial cornea and corneal implant market. Besides this, the increasing need for penetrating keratoplasty procedures that assist in treating ecstatic corneal diseases, such as keratoconus and pellucid marginal degeneration, is further augmenting the market growth. Apart from this, the elevating product innovations, including the development of three-dimensional (3D) printed artificial corneas with enhanced biocompatibility and customizability, are also catalyzing the global market. Moreover, the escalating product demand to treat cloudy cornea caused by prolonged exposure to digital screens is expected to bolster the artificial cornea and corneal implant market in the coming years. Request for a free sample report: https://www.imarcgroup.com/artificial-cornea-corneal-implant- market/requestsample

5. Report Description Report Description and Highlights Market Summary: Breakup by Type: • • Human Cornea Artificial Cornea Breakup by Transplant Type: • • • • Penetrating Keratoplasty Endothelial Keratoplasty Anterior Lamellar Keratoplasty Keratoprosthesis Breakup by Disease Indication: • • • • Fuchs’ Dystrophy Fungal Keratitis Keratoconus Others

6. Report Description Report Description and Highlights Breakup by End User: • • • Hospitals Ambulatory Surgical Centers Specialty Clinics Breakup by Region: • • • • • North America Europe Asia Pacific Middle East and Africa Latin America On account of the aforementioned factors, the market is anticipated to witness strong growth during 2023-2028.

7. Report Description Report Description and Highlights Competitive Landscape With Key player: • • • • • • • • • • • • Advancing Sight Network AJL Ophthalmic S.A. Aurolab Corneat Vision Ltd EyeYon Medical Florida Lions Eye Bank Keramed Inc. L V Prasad Eye Institute LinkoCare Life Sciences AB Mediphacos Presbia PLC San Diego Eye Bank View Report TOC, Figures and Tables: https://www.imarcgroup.com/artificial-cornea-corneal- implant-market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019IMARC All RightsReserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of InternationalMarket Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss ordamage resulting fromopinion, errors orinaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com